PT  - JOURNAL ARTICLE
AU  - Sánchez-Taltavull, Daniel
AU  - Candinas, Daniel
AU  - Roldán, Édgar
AU  - Beldi, Guido
TI  - Modelling strategies to organize healthcare workforce during pandemics: application to COVID-19
AID  - 10.1101/2020.03.23.20041863
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.23.20041863
4099  - http://medrxiv.org/content/early/2020/06/25/2020.03.23.20041863.short
4100  - http://medrxiv.org/content/early/2020/06/25/2020.03.23.20041863.full
AB  - Protection of healthcare workforce who are at increased risk to become infected is of paramount relevance for the care of patients in the setting of a pandemic such as coronavirus disease 2019 (COVID-19). The ideal organisational strategy to protect the workforce in a situation in which social distancing cannot be maintained remains to be determined. In this study, we have mathematically modelled strategies for the employment of hospital workforce with the goal to simulate health and productivity of the workers. The models were designed to determine if desynchronization of medical teams by dichotomizing the workers may protect the workforce. Our studies model workforce productivity depending on the infection rate, the presence of reinfection and the efficiency of home office and apply our theory to the case of COVID-19. The results reveal that a desynchronization strategy in which two medical teams work alternating for 7 days increases the available workforce.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the manuscript.